Showing results (161-170 of 186) with videos related to
Sort By:
Pageof 19
Renal Failure|November 21, 2009
Kidney function and 24-hour proteinuria in patients with Fabry disease during 36 months of agalsidase alfa enzyme replacement therapy: a Brazilian experienceScheila Thofehrn, Cristina Netto, Cláudia Cecchin, et al.Toxicology|March 14, 2008
Adult derived mononuclear bone marrow cells improve survival in a model of acetaminophen-induced acute liver failure in ratsMaria Cristina Belardinelli, Fernanda Pereira, Guilherme Baldo, et al.Advances in Hematology|November 30, 2012
DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South BrazilAnnelise Pezzi, Lauro Moraes, Vanessa Valim, et al.Plos One|March 6, 2014
Increased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type IValeska Lizzi Lagranha, Ursula Matte, Talita Giacomet de Carvalho, et al.Journal of Inherited Metabolic Disease|January 26, 2026
Molecular Profile of Mucopolysaccharidosis Type I Patients in BrazilCarlos Robson Costa Cruz, Edina Poletto, Larissa Mota Silva, et al.Pharmaceutical Research|September 12, 2014
Laronidase-functionalized multiple-wall lipid-core nanocapsules: promising formulation for a more effective treatment of mucopolysaccharidosis type IFabiana Quoos Mayer, Márcia Duarte Adorne, Eduardo André Bender, et al.Renal Failure|October 18, 2008
Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical reportDaiana Benck Porsch, Ane Cláudia Fernandes Nunes, Vagner Milani, et al.Expert Opinion on Emerging Drugs|January 12, 2016
Emerging drugs for the treatment of mucopolysaccharidosesRoberto Giugliani, Andressa Federhen, Filippo Vairo, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|July 31, 2012
RGD-based cell ligands for cell-targeted drug delivery act as potent trophic factorsJoan Domingo-Espín, Valérie Petegnief, Núria de Vera, et al.Pharmaceutics|March 28, 2026
Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type IHallana Souza Santos, Edina Poletto, Luisa Natalia Pimentel Vera, et al.Pageof 19